Proportion of isolates with decreased susceptibility or resistance in Sweden

Sweden: Proportion of isolates with decreased susceptibility or resistance was 1.5 in 2018. ◆ Volatile

Latest (2018)
1.5
Change on year
down 25.0%
World rank
9th
of 27 countries
All-time high
7.62
in 2011
All-time low
0
in 2012
Years of data
10
2009–2018

Proportion of isolates with decreased susceptibility or resistance in Sweden, 2009–2018

024682009201320182009: 2.82010: 7.12011: 7.62012: 02013: 02014: 02015: 02016: 02017: 22018: 1.5

Source: World Health Organization, Global Health Observatory.

Analysis

In 2018, proportion of isolates with decreased susceptibility or resistance in Sweden stood at 1.5.

The figure is down 25.0% on the previous year and down 46.0% over ten years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in Sweden peaked at 7.62 in 2011 and was at its lowest, 0, in 2012.

That places Sweden 9th out of 27 countries with data for 2018, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in Sweden, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP in Sweden, 2009 to 2018.
Year Value Change
2009 2.78
2010 7.14 +157.1%
2011 7.62 +6.7%
2012 0 -100.0%
2013 0
2014 0
2015 0
2016 0
2017 2
2018 1.5 -25.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 2.78 2.78 2.78 1
2010s 2.03 0 7.62 9

Countries ranked near Sweden

  1. 6 Austria 3.4 compare
  2. 7 Belgium 2.9 compare
  3. 8 Hungary 2.2 compare
  4. 10 Poland 1.4 compare
  5. 11 United Kingdom of Great Britain and Northern Ireland 1.2 compare
  6. 12 Germany 1 compare

See the full ranking of 27 places →

More health data for Sweden

All data for Sweden →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in Sweden?
Proportion of isolates with decreased susceptibility or resistance in Sweden was 1.5 in 2018, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Sweden?
The highest recorded value was 7.62 in 2011.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Sweden?
The lowest recorded value was 0 in 2012.
How does Sweden rank for proportion of isolates with decreased susceptibility or resistance?
Sweden ranks 9th out of 27 countries with data for 2018.
Is proportion of isolates with decreased susceptibility or resistance rising or falling in Sweden?
Over the last ten years it is down 46.0%. The long-run trend across the full record is volatile.
Where does this Sweden data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in Sweden. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 09 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-cefixime/sweden/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-cefixime/sweden/">Proportion of isolates with decreased susceptibility or resistance in Sweden</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
27 places, 246 data points, 2009–2018
Last refreshed